EPISODE · Jan 10, 2025 · 14 MIN
An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)
from The Top Line · host Fierce Life Sciences
Arun Krishna, Vice President and franchise head for an AstraZeneca US OBU, shares details of a treatment option with TAGRISSO® (osimertinib). AstraZeneca is focused on the development of new treatments, prioritizing researching options in eligible patients. Listen to the full podcast episode to learn more. Please see Important Safety Information for TAGRISSO. Please see complete Prescribing Information, including Patient Information for TAGRISSO.See omnystudio.com/listener for privacy information.
What this episode covers
Arun Krishna, VP and franchise head for an AstraZeneca US OBU, discusses a treatment option for patients.
NOW PLAYING
An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m